Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Stock Hits QuantWave Forecast Target with 31.15% Profit

May 09, 2024
On June 10, 2022, QuantWave's automated forecasting platform issued a long signal for ASTRAZENECA PLC (AZN) when the stock was trading at $57.99. The platform predicted a price target of $76.05, which was achieved on May 09, 2024. This successful forecast resulted in a profit of 31.15% for investors who followed the signal.

The stock's movement can be attributed to several factors, including positive developments in the pharmaceutical industry, strong financial performance by ASTRAZENECA PLC, and overall market sentiment towards healthcare stocks during the forecast period.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting price movements for various stocks. By providing users with timely and reliable forecasts, QuantWave offers opportunities for traders and investors to capitalize on market trends and potentially increase their returns.

For those interested in exploring QuantWave's forecasting capabilities further, we recommend checking out QuantSchool, a professional investment framework that provides educational resources on using the platform to generate consistent income. With QuantWave and QuantSchool, investors can gain valuable insights and enhance their investment strategies.

Find out how the ASTRAZENECA PLC rate is expected to change

Get Forecast for AZN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for AZN

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....



Related news

AZNDecember 7, 2024Why AstraZeneca PLC AZN is Revolutionizing the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....

AstraZeneca PLC: Promising Investment Opportunity in the Healthcare Sector  ~3 min.

AstraZeneca PLC, a leading pharmaceutical company, is currently focusing on expanding its presence in the United States....

AZNDecember 1, 2024Why AstraZeneca PLC AZN is Gaining Momentum in the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC (AZN) has been making headlines in the pharmaceutical industry due to its promising prospects and investment potential....

AZNDecember 9, 2024Is AstraZeneca PLC AZN the Most Profitable Pharmaceutical Stock Right Now?  ~2 min.

AstraZeneca PLC (AZN) is emerging as one of the most profitable pharmaceutical stocks in the market....

AZNNovember 4, 2024AstraZeneca Announces Share Capital Details - Stocks Prognosis Recommends Buying AZN Shares  ~2 min.

AstraZeneca PLC, a renowned pharmaceutical company, recently revealed its share capital details. This news has attracted the attention of investors worldwide....